Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device
Abstract Introduction COVID‐19 drastically impacted the landscape of the United States’ medical system. Limited data is available on the nationwide implantation trends in Cardiac Resynchronization Therapy Defibrillator (CRT‐D) devices before and during the pandemic. We aimed to explore the impact of...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-04-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/joa3.12994 |
| _version_ | 1797221577572483072 |
|---|---|
| author | Anmol Johal Ndausung Udongwo Steven Imburgio Anton Mararenko Hira Akhlaq Sowmya Dandu Temidayo Abe Jesus Almendral Joseph Heaton Riple Hansalia |
| author_facet | Anmol Johal Ndausung Udongwo Steven Imburgio Anton Mararenko Hira Akhlaq Sowmya Dandu Temidayo Abe Jesus Almendral Joseph Heaton Riple Hansalia |
| author_sort | Anmol Johal |
| collection | DOAJ |
| description | Abstract Introduction COVID‐19 drastically impacted the landscape of the United States’ medical system. Limited data is available on the nationwide implantation trends in Cardiac Resynchronization Therapy Defibrillator (CRT‐D) devices before and during the pandemic. We aimed to explore the impact of the COVID‐19 pandemic on CRT‐D insertion rates and adverse outcomes related to delays in care. Methods and Results We conducted a retrospective cross‐sectional analysis using the National Inpatient Sample database between 2017 and 2020. Variables were identified using their ICD‐10 codes. Inclusion criteria: age ≥ 18 years, presenting for a nonelective admission, primary diagnosis of hypertensive heart disease, hypertensive heart, chronic kidney disease, or heart failure, and underwent insertion of a CRT‐D. Between 2017 and 2020, CRT‐D devices were inserted during 23,635 admissions. On average, 6198 devices were implanted yearly from 2017 to 2019, with only 5040 devices being implanted in 2020. Additionally, reduced implantation rates were noted for every cohort of hospital size, location, and teaching status during this year. The year 2020 also had the highest average death rate at 1.39%, but this difference was statistically insignificant (adjusted Wald test p = .767), and COVID‐19 was not associated with an increased risk of inpatient mortality (OR 0.22, 95% CI 0.03–1.82, p = .162). Conclusion The COVID‐19 pandemic has affected all facets of the healthcare system, especially surgical volume rates. CRT‐D procedures significantly decreased in 2020. This is the first retrospective study highlighting the trend of reduced rates of CRT‐D implantation as a response to the COVID‐19 pandemic. |
| first_indexed | 2024-04-24T13:07:39Z |
| format | Article |
| id | doaj.art-b3966a9609234ff2b7b84f761f680f20 |
| institution | Directory Open Access Journal |
| issn | 1880-4276 1883-2148 |
| language | English |
| last_indexed | 2024-04-24T13:07:39Z |
| publishDate | 2024-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Arrhythmia |
| spelling | doaj.art-b3966a9609234ff2b7b84f761f680f202024-04-05T07:21:50ZengWileyJournal of Arrhythmia1880-42761883-21482024-04-0140223724610.1002/joa3.12994Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator deviceAnmol Johal0Ndausung Udongwo1Steven Imburgio2Anton Mararenko3Hira Akhlaq4Sowmya Dandu5Temidayo Abe6Jesus Almendral7Joseph Heaton8Riple Hansalia9Department of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Cardiology Vanderbilt University Medical Center Nashville Tennessee USADepartment of Cardiology Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Medicine Jersey Shore University Medical Center Neptune City New Jersey USADepartment of Cardiology Jersey Shore University Medical Center Neptune City New Jersey USAAbstract Introduction COVID‐19 drastically impacted the landscape of the United States’ medical system. Limited data is available on the nationwide implantation trends in Cardiac Resynchronization Therapy Defibrillator (CRT‐D) devices before and during the pandemic. We aimed to explore the impact of the COVID‐19 pandemic on CRT‐D insertion rates and adverse outcomes related to delays in care. Methods and Results We conducted a retrospective cross‐sectional analysis using the National Inpatient Sample database between 2017 and 2020. Variables were identified using their ICD‐10 codes. Inclusion criteria: age ≥ 18 years, presenting for a nonelective admission, primary diagnosis of hypertensive heart disease, hypertensive heart, chronic kidney disease, or heart failure, and underwent insertion of a CRT‐D. Between 2017 and 2020, CRT‐D devices were inserted during 23,635 admissions. On average, 6198 devices were implanted yearly from 2017 to 2019, with only 5040 devices being implanted in 2020. Additionally, reduced implantation rates were noted for every cohort of hospital size, location, and teaching status during this year. The year 2020 also had the highest average death rate at 1.39%, but this difference was statistically insignificant (adjusted Wald test p = .767), and COVID‐19 was not associated with an increased risk of inpatient mortality (OR 0.22, 95% CI 0.03–1.82, p = .162). Conclusion The COVID‐19 pandemic has affected all facets of the healthcare system, especially surgical volume rates. CRT‐D procedures significantly decreased in 2020. This is the first retrospective study highlighting the trend of reduced rates of CRT‐D implantation as a response to the COVID‐19 pandemic.https://doi.org/10.1002/joa3.12994cardiac resynchronization therapyCOVID‐19CRT‐Ddefibrillatorheart failure |
| spellingShingle | Anmol Johal Ndausung Udongwo Steven Imburgio Anton Mararenko Hira Akhlaq Sowmya Dandu Temidayo Abe Jesus Almendral Joseph Heaton Riple Hansalia Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device Journal of Arrhythmia cardiac resynchronization therapy COVID‐19 CRT‐D defibrillator heart failure |
| title | Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| title_full | Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| title_fullStr | Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| title_full_unstemmed | Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| title_short | Negative effects of COVID‐19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| title_sort | negative effects of covid 19 on the implantation rate of cardiac resynchronization therapy with defibrillator device |
| topic | cardiac resynchronization therapy COVID‐19 CRT‐D defibrillator heart failure |
| url | https://doi.org/10.1002/joa3.12994 |
| work_keys_str_mv | AT anmoljohal negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT ndausungudongwo negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT stevenimburgio negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT antonmararenko negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT hiraakhlaq negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT sowmyadandu negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT temidayoabe negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT jesusalmendral negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT josephheaton negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice AT riplehansalia negativeeffectsofcovid19ontheimplantationrateofcardiacresynchronizationtherapywithdefibrillatordevice |